Close Menu

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Verily Life Science's molecular SARS-CoV-2 test.

The Verily COVID-19 RT-PCR Test is designed to detect the ORF1ab, N, and S genes of SARS-CoV-2 in upper respiratory specimens and can be used with pooled samples containing up to 12 individual specimens collected by healthcare providers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.